| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Amedisys, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$38.94 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 0.89 |
| 1 Month Change | 0.18% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 8.77% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| A2ME34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | -0.2% |
| 1Y | n/a | -22.7% | -2.6% |
Return vs Industry: Insufficient data to determine how A2ME34 performed against the BR Healthcare industry.
Return vs Market: Insufficient data to determine how A2ME34 performed against the BR Market.
Price Volatility
| A2ME34 volatility | |
|---|---|
| A2ME34 Average Weekly Movement | 1.8% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 9.2% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: A2ME34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine A2ME34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 20,000 | Richard Ashworth | www.amedisys.com |
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Amedisys, Inc. Fundamentals Summary
| A2ME34 fundamental statistics | |
|---|---|
| Market cap | R$15.14b |
| Earnings (TTM) | R$13.03m |
| Revenue (TTM) | R$10.96b |
1,163x
P/E Ratio1.4x
P/S RatioIs A2ME34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A2ME34 income statement (TTM) | |
|---|---|
| Revenue | US$2.23b |
| Cost of Revenue | US$1.24b |
| Gross Profit | US$986.40m |
| Other Expenses | US$983.75m |
| Earnings | US$2.65m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.081 |
| Gross Margin | 44.28% |
| Net Profit Margin | 0.12% |
| Debt/Equity Ratio | 34.3% |
How did A2ME34 perform over the long term?
See historical performance and comparison